ULU KILIÇ, A. Et Al. 2013. Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli. 23rd European Congress of Clinical Microbiology an Infectious Diseases , (Germany), 170.

ULU KILIÇ, A., UYSAL, B., METAN, G., DEMİRASLAN, H., & DOĞANAY, M., (2013). Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli . 23rd European Congress of Clinical Microbiology an Infectious Diseases (pp.170). , Germany

ULU KILIÇ, Ayşegül Et Al. "Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli," 23rd European Congress of Clinical Microbiology an Infectious Diseases, Germany, 2013

ULU KILIÇ, Ayşegül U. Et Al. "Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli." 23rd European Congress of Clinical Microbiology an Infectious Diseases , Germany, pp.170, 2013

ULU KILIÇ, A. Et Al. (2013) . "Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli." 23rd European Congress of Clinical Microbiology an Infectious Diseases , Germany, p.170.

@conferencepaper{conferencepaper, author={Ayşegül ULU KILIÇ Et Al. }, title={Piperacillin/tazobactam versus carbapenems in the treatment of urinary tract infections caused by extended-spectrum beta-lactamases-producing Escherichia coli}, congress name={23rd European Congress of Clinical Microbiology an Infectious Diseases}, city={}, country={Germany}, year={2013}, pages={170} }